ClinicalTrials.gg
Sign In
RecruitingNCT07769151Updated Oct 19, 2026

BIO-FUNCTION for Prediction Non Relapse Mortality in Transplant and Cell Therapy

An observational study in Mortality Prediction, sponsored by Henry Ford Health System. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by Henry Ford Health System · Observational

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Oct 14, 2026Start date movedEligibility revisedGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
124
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this research is test if combination of physical tests and blood tests drawn before SCTCT can predict NRM.

02

Conditions studied

  • Mortality Prediction
03

In context

Lead sponsor

Henry Ford Health System is the lead sponsor of 303 studies on the registry; 50 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 26 (70%) have results posted.

Browse Henry Ford Health System studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Oct 14, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients >18 year old planned for SCTCT

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients >18 year old
  • patients planned for SCTCT

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • prisoners
  • Patients with a serious medical or psychiatric illness likely to interfere with participation in this clinical study
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
124 participants (estimated)
Patient registry
No

Interventions

  • Diagnostic testblood sample to check CXCL9 pre stem cell transplant and cell therapy

    Pre SCTCT as per SOC physical function assessment will be performed in a form of IADl, hand grip, and or walk test like TUG. Specimen Collection Studies: LDH , albumin, ferritin, CRP, platelet and creatinine will be collected as per standard of care pre SCTCT. The non-SOC procedure will be drawing CXL9

06

What researchers measure

Primary outcomes

  1. Non relapse mortality (NRM)

    Time frame: NRM at day 100 and at year 1

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Oct 2026 (actual). Primary completion is estimated for Dec 2030, 50 months after the start.

Start moved once since we started tracking on Sep 25, 2026: Sep 2026 → Oct 2026, on Oct 14, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 12, 2026
First posted
Aug 17, 2026
StartActual
Oct 1, 2026was Sep 2026
Primary completionEst.
Dec 30, 2030
CompletionEst.
Dec 30, 2031
Last update
Oct 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Sep 1, 2026→Oct 1, 2026 (actual)
Oct 14, 2026
Eligibility
1 inclusion criterion edited, 1 added; 1 exclusion criterion edited, 2 added
What changed in the criteria
Inclusion criteria
  • Editedpatients >18 year old planned for SCTCT
  • Addedpatients planned for SCTCT
Exclusion criteria
  • AddedPregnancy
  • Addedprisoners
  • EditedPregnancy, prisoners , Patients with a serious medical or psychiatric illness likely to interfere with participation in this clinical study
Oct 14, 2026
Show all 2 updates
  1. Oct 19, 2026
    Minor edits only
    + 1 other change: responsible party
  2. Oct 14, 2026
    Start date Sep 1, 2026→Oct 1, 2026 (now actual)
    Eligibility 1 inclusion criterion edited, 1 added; 1 exclusion criterion edited, 2 added
    What changed in the criteria
    Inclusion criteria
    • Editedpatients >18 year old planned for SCTCT
    • Addedpatients planned for SCTCT
    Exclusion criteria
    • AddedPregnancy
    • Addedprisoners
    • EditedPregnancy, prisoners , Patients with a serious medical or psychiatric illness likely to interfere with participation in this clinical study
    + 2 other changes: verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07769151
Lead sponsor
Henry Ford Health System
Responsible party
Shatha Farhan (Principal Investigator, Henry Ford Health System) — Principal investigator
First posted
Aug 17, 2026
Start date
Oct 1, 2026
Primary completion
Dec 30, 2030 (estimated)
Completion
Dec 30, 2031 (estimated)
Last update
Oct 19, 2026

Study contacts

Shatha Farhan, MD
Contact
sfarhan1@hfhs.org
3137133910
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Henry Ford Health System →

Start the discussion